Search Results - "Lai, Hock C."

Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials by Au, Minnie, Emeto, Theophilus I, Power, Jacinta, Vangaveti, Venkat N, Lai, Hock C

“…Pancreatic cancer is an aggressive disease with a five year survival rate of less than 5%, which is associated with late presentation. In recent years,…”
Get full text

A comprehensive study of the epidemiology of haematological malignancies in North Queensland by Nath, Karthik, Boles, Rachael, Emeto, Theophilus I., Adegboye, Oyelola A., Castellanos, Maria Eugenia, Alele, Faith O., Pearce, Jessica, Ewart, Barbara, Ward, Kayla, Lai, Hock C., Morris, Edward, Hodges, Georgina, Irving, Ian

“…Background There is an absence of clinically relevant epidemiological data in regional Australia pertaining to haematological malignancies. Aim To determine…”
Get full text

A 14‐year retrospective analysis of indications and outcomes of autologous haemopoietic stem cell transplantation in regional Queensland: a single‐centre experience by Hamilton, Elizabeth M., Nath, Karthik D., Vangaveti, Venkat N., McCutchan, Andrew D., Marsh, Jodie L., Birchley, Andrew J., Casey, John M., McNamara, Caroline, Lai, Hock C., Morris, Edward S., Hodges, Georgina, Irving, Ian M.

“…Background The Townsville Hospital is a tertiary hospital in North Queensland with one of the largest regional transplant centres in Australia, performing…”
Get full text

A randomized, open-label, phase 3 study of low-dose selinexor and lenalidomide (Len) versus len maintenance post autologous stem cell transplant (ASCT) for newly diagnosed multiple myeloma (NDMM): ALLG MM23, Sealand by Quach, Hang, Lasica, Masa, Routledge, David, Kalff, Anna, Lim, Andrew, Low, Michael, Estell, Jane A., Sidiqi, M Hasib, Campbell, Philip, Eek, Richard Wilhelm, Lai, Hock C., McCaughan, Georgia J., D'Rozario, James, Browlett, Peter, Rajagopal, Rajeev, Heenan, Jessica, Murphy, Nicholas E, Renwick, William, Huan, Georgina, Mollee, Peter

“…Abstract only TPS8055 Background: Len maintenance post ASCT is standard of care for patients (pts) with NDMM. Deep responses (CR or better) post ASCT…”
Get full text

A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial by Dennis, Mike, Hills, Robert, Thomas, Ian, Ariti, Cono, Severinsen, Marianne T., Clark, Richard E., Copland, Mhairi, Russell, Nigel, Kallenbach, Maria, Culligan, Dominic, Duncan, Caroline, Krishnamurthy, Pramila, Cuthbert, Ann, Spanoudakis, Michail, Galvani, David, Berkahn, I., Jasani, Parag, Parker, Anne, Arnold, Claire, Cuthbert, Robert, Finnega, Damien, Pratt, Guy, Cahalin, Paul, Ackroyd, Sam, Protheroe, Rachel, Weinkove, Robert, Ali, Sara, Smith, Mark, Spearing, Ruth, Campbell, Gavin, Hamblin, Mike, Wood, Marion, Pillai, Arvind, Rule, Simon, Neilson, Roderick, Lush, Richard, Swe, Wunna, Chalmers, Isobel, Prahladan, Mahesh, Kwan, Mark, Lyttleton, Matthew, Martin, Alexander M., Saravanamuttu, Kandeepan, Saif, Muhammad, Tholouli, Eleni, Andrews, Vivienne, Jackson, Sharon, Gordon, William, Bowen, Angela, McGrann, Alistair, Mittal, Sajjan, Byrne, Jenny, Das‐Gupta, Emma, Radia, Rohini, Baker, Bart, Kilfoyle, Allanah, Knottenbelt, Elayne, Rinaldi, Ciro, Furby, Darshyani, Alderman, Charles, Belsham, Edward, Corser, Robert, Dignum, Helen, Mohan, Mahalakshmi, Kampman, Peter, Kjeldsen, Lars, Mourek, Jindrich, Nielsen, Ove J., Niemann, Carsten U., Khan, Asif, Sampson, Rebecca, Veale, D, Kottaridis, Panagiotis, Cullis, Jonathan, Grand, Effie, Wandroo, Farooq, O'Brien, David, Nicholson, Toby, Janes, Sarah, Galloway, Mike, Mathew, Susanna, Green, Sarah, Mamadigi, Rajesh, Plews, Diane, Chacko, Joseph, Salim, Rahuman, Allameddine, Allameddine, Greenfield, Hayley, Osborne, David, Hodges, Georgina, Carrington, Patrick, Sadik, Walid, Yung, Lynny, Alvares, Caroline, Goodman, Hugh, Aitchison, Robin, Pattinson, Jonathan, Pushkaran, Beena, Edwards, David, Seale, Jim

“…Summary Older patients with acute myeloid leukaemia (AML) account for nearly half of those with the disease. Because they are perceived to be unfit for,…”
Get full text